<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> &#187; Technology</title>
	<atom:link href="http://pharmaexecnews.com/category/biotechnology/technology/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmaexecnews.com</link>
	<description></description>
	<lastBuildDate>Fri, 29 Apr 2011 14:00:12 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Targeted Photodynamic Therapy for Treating Skin Cancer</title>
		<link>http://pharmaexecnews.com/biotechnology/targeted-photodynamic-therapy-treating-skin-cancer/</link>
		<comments>http://pharmaexecnews.com/biotechnology/targeted-photodynamic-therapy-treating-skin-cancer/#comments</comments>
		<pubDate>Fri, 22 Apr 2011 14:00:28 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Technology]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11481</guid>
		<description><![CDATA[Research by Swiss and British scientists has shown that targeted photodynamic therapy has the potential to completely eradicate some models of cancer.  The team – consisting of researchers from the University of Hull and ETH Zurich – combined light-sensitive molecules with antibodies that specifically target tumor blood vessels. When irradiated with light, the molecules produce [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/targeted-photodynamic-therapy-treating-skin-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Classification for E. Coli Bacteria</title>
		<link>http://pharmaexecnews.com/biotechnology/classification-coli-bacteria/</link>
		<comments>http://pharmaexecnews.com/biotechnology/classification-coli-bacteria/#comments</comments>
		<pubDate>Thu, 21 Apr 2011 14:00:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Technology]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11489</guid>
		<description><![CDATA[The standard fecal coliform test that is used for monitoring the quality of water is being questioned by a latest research study that has identified sources of Escherichia coli bacteria that may not indicate an environmental hazard.

Fecal pollution of surface waters is quantified by the concentration of E. coli bacteria in the water as E. [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/classification-coli-bacteria/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Generation of Medicines with Evolution of Biomolecules</title>
		<link>http://pharmaexecnews.com/biotechnology/generation-medicines-evolution-biomolecules/</link>
		<comments>http://pharmaexecnews.com/biotechnology/generation-medicines-evolution-biomolecules/#comments</comments>
		<pubDate>Wed, 20 Apr 2011 08:00:47 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Technology]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11477</guid>
		<description><![CDATA[A research team from the Harvard University has harnessed the ability of fast-replicating bacterial viruses, also known as phages, to accelerate the evolution of biomolecules in the laboratory. This latest research has the potential to ultimately allow the tailoring of custom pharmaceuticals and research tools from lab-grown proteins, nucleic acids, and other such compounds.

The researchers, [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/generation-medicines-evolution-biomolecules/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Turning Blood Cells into &#8216;Beating&#8217; Heart Cells</title>
		<link>http://pharmaexecnews.com/biotechnology/turning-blood-cells-beating-heart-cells/</link>
		<comments>http://pharmaexecnews.com/biotechnology/turning-blood-cells-beating-heart-cells/#comments</comments>
		<pubDate>Tue, 19 Apr 2011 14:00:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cardiovascular]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Technology]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11473</guid>
		<description><![CDATA[Researchers from Johns Hopkins have produced a simplified, cheaper, all-purpose produces they say can be utilized by scientists around the world to more safely turn blood cells into heart cells. The procedure developed by them is virus-free and produces heart cells that beat with nearly 100 percent efficiency.

&#8220;We took the recipe for this process from [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/turning-blood-cells-beating-heart-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diagnosing Genetic Mutations with the Help of New Technology</title>
		<link>http://pharmaexecnews.com/biotechnology/diagnosing-genetic-mutations-technology/</link>
		<comments>http://pharmaexecnews.com/biotechnology/diagnosing-genetic-mutations-technology/#comments</comments>
		<pubDate>Mon, 18 Apr 2011 09:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Technology]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11462</guid>
		<description><![CDATA[Even one minute alteration one of the thousands of DNA codes that constitute each gene in the human genome can lead to severe diseases such as cancer, cystic fibrosis, muscular dystrophy or Huntington&#8217;s Disease. A similarly miniscule alteration in the DNA of a virus or bacteria can lead to drug resistant strains that are difficult [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/diagnosing-genetic-mutations-technology/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Seat of Fear Discovered in the Brain</title>
		<link>http://pharmaexecnews.com/biotechnology/seat-fear-discovered-brain/</link>
		<comments>http://pharmaexecnews.com/biotechnology/seat-fear-discovered-brain/#comments</comments>
		<pubDate>Fri, 18 Mar 2011 08:00:33 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Devices and Technology]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11324</guid>
		<description><![CDATA[Researchers have been long trying to figure out the basics of the very feeling of fear. Now, researchers from the Stanford University School of Medicine have discovered that stimulation of a distinct brain circuit that lies within a brain structure generally linked with fearfulness produces the opposite effect: Its activity, instead of triggering or increasing [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/seat-fear-discovered-brain/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ACT Inc Receives Patent for Generating Embryonic Stem Cells minus Embryo Destruction</title>
		<link>http://pharmaexecnews.com/biotechnology/act-receives-patent-generating-embryonic-stem-cells-embryo-destruction/</link>
		<comments>http://pharmaexecnews.com/biotechnology/act-receives-patent-generating-embryonic-stem-cells-embryo-destruction/#comments</comments>
		<pubDate>Thu, 17 Mar 2011 08:00:40 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[understanding stem cell research]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11316</guid>
		<description><![CDATA[In a revolutionary development, Advanced Cell Technology, Inc., a leading biotechnology company applying cellular technology in the field of regenerative medicine, has announced that it has gotten the go ahead for developing its single-blastomere technique. The company has been issued a patent for its single-blastomere technology that provides an alternative manner of deriving human embryonic [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/act-receives-patent-generating-embryonic-stem-cells-embryo-destruction/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Printers Used to Produce Human Skin?</title>
		<link>http://pharmaexecnews.com/biotechnology/printers-produce-human-skin/</link>
		<comments>http://pharmaexecnews.com/biotechnology/printers-produce-human-skin/#comments</comments>
		<pubDate>Thu, 03 Mar 2011 08:00:32 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[dna]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11211</guid>
		<description><![CDATA[U.S. medical researchers are using modified printers to produce skin for burn victims, the project&#8217;s leader says. &#8220;We started out by taking a typical desktop inkjet cartridge. Instead of ink we use cells, which are placed in the cartridge,&#8221; Dr. Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine in Winston-Salem, N.C., told [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/printers-produce-human-skin/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Delivering a Potent Cancer Drug with Nanoparticles can Lessen Side Effects</title>
		<link>http://pharmaexecnews.com/biotechnology/delivering-potent-cancer-drug-nanoparticles-lessen-side-effects/</link>
		<comments>http://pharmaexecnews.com/biotechnology/delivering-potent-cancer-drug-nanoparticles-lessen-side-effects/#comments</comments>
		<pubDate>Wed, 23 Feb 2011 08:00:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Nanotechnology]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11189</guid>
		<description><![CDATA[Researchers at MIT and Brigham and Women&#8217;s Hospital have shown that they can deliver the cancer drug cisplatin much more effectively and safely in a form that has been encapsulated in a nanoparticle targeted to prostate tumor cells and is activated once it reaches its target.  Using the new particles, the researchers were able to [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/delivering-potent-cancer-drug-nanoparticles-lessen-side-effects/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Small Details between &#8216;In Vivo&#8217; and &#8216;In Vitro&#8217; Studies Make for Big Differences</title>
		<link>http://pharmaexecnews.com/biotechnology/small-details-in-vivo-in-vitro-studies-big-differences/</link>
		<comments>http://pharmaexecnews.com/biotechnology/small-details-in-vivo-in-vitro-studies-big-differences/#comments</comments>
		<pubDate>Tue, 22 Feb 2011 08:00:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11185</guid>
		<description><![CDATA[Exocytosis, the fundamental process by which cells secrete hormones such as insulin and other useful biological substances, is regulated far differently in life than in laboratory tissue cultures and explanted organs, according to research presented at the American Society of Cell Biology&#8217;s 50th Annual Meeting in Philadelphia.  The unexpected findings that exocytosis regulation &#8220;in vivo&#8221; [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/small-details-in-vivo-in-vitro-studies-big-differences/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

